Appointed
Andrea Wainer
Director
NEOG ·
NEOGEN CORP
Replacing Mr. Tobin, Neogen appoints Andrea Wainer to Neogen’s Board of Directors, effective June 1, 2025.
Ready 8-Ks
34
Latest filing
April 20, 2026, 7:59 PM ET
Top materiality
0.80
Event mix
leadership ×14 · earnings ×9 · other_material ×8
Sentiment
4 pos · 9 neg · 21 neu
Latest earnings
reported 2026-Q3
Executive change
recent →
Recent 8-K filings for NEOG
Highest-materiality recent filing
Neogen Q1 FY2026 revenue $209.2M, net income $36.3M; new CEO Mike Nassif
- Revenue $209.2M, net income $36.3M; adjusted net income $9.4M, adjusted EBITDA $35.5M.
- Completed divestiture of Cleaners & Disinfectants business and repaid $100M debt.
-
Neogen completes operational qualifications for Petrifilm SKUs; moves to performance qualifications
Successfully completed multiple operational qualifications for certain Petrifilm single kit units (SKUs).
-
Neogen Q3 FY26 revenue $211.2M; net loss $17M; divests Genomics unit
Revenue $211.2M; Food Safety core growth +4.0%, Animal Safety core growth –8.7% on supplier challenges.
-
Neogen's Chief Legal and Administrative Officer Amy Rocklin to depart March 31, 2026
Amy Rocklin, Chief Legal and Administrative Officer, is leaving Neogen effective March 31, 2026.
-
Neogen Q2 revenue $224.7M (-2.8% YoY); core growth +2.9%; raises FY guidance
Net loss of $15.9M; adjusted net income of $22.6M; adjusted EBITDA of $48.7M.
-
Neogen appoints Bryan Riggsbee as CFO effective Nov 3, 2025
Riggsbee named SVP & CFO, succeeding David Naemura who remains through end of 2025 to aid transition.
-
Neogen assigns new director Avi Pelossof to Audit and Compensation Committees
Avi Pelossof appointed to Audit Committee and Compensation and Talent Management Committees effective October 24, 2025.
-
Neogen amends 8-K to show shareholders approved executive compensation proposal
Original 8-K incorrectly reported Proposal 2 (say-on-pay) as not approved; corrected to show approval.
-
Neogen shareholders reject say-on-pay at 2025 annual meeting
Directors Thierry L. Bernard, Mikhael Nassif, Avi Pelossof, Andrea F. Wainer elected with >90% support.
-
Neogen Q1 FY2026 revenue $209.2M, net income $36.3M; new CEO Mike Nassif
Revenue $209.2M, net income $36.3M; adjusted net income $9.4M, adjusted EBITDA $35.5M.
-
Neogen CFO & COO David Naemura resigns voluntarily; successor search underway
Naemura will remain CFO/COO until October filing of 10-Q, no later than Dec 31, 2025.
-
Neogen grants PSUs and stock options to CEO and other NEOs for FY2026 LTI
CEO Mikhael Nassif receives 414,365 PSUs (target) and 1,065,042 options at $5.43 strike, vesting over 3 years.
-
Neogen announces board retirement of William Boehm, appointment of Avi Pelossof effective Oct 23/24
William T. Boehm to retire from Neogen's Board effective Oct 23, 2025; served since 2011, chairs Audit Committee, member of Compensation & Talent Management Committee.
-
Neogen Q4 FY2025 revenue $225.5M; net loss $612.2M on goodwill impairment; adj. EPS $0.05
Revenue $225.5M; net loss $612.2M ($2.82 diluted loss) primarily from non-cash goodwill impairment.
-
Neogen appoints Mikhael Nassif as President and CEO effective August 11, 2025
Mikhael Nassif, former Siemens Healthineers Global President of Point-of-Care Diagnostics, appointed CEO.
-
Neogen furnishes investor presentation at William Blair conference; no specifics in filing
Neogen presented at the William Blair Growth Stock Conference on June 4, 2025.
-
Neogen furnishes slides for BofA Healthcare Conference; no material new data provided
Presentation at 2025 Bank of America Healthcare Conference on May 14.
-
Neogen announces board retirement of James P. Tobin, appoints Andrea Wainer effective June 1, 2025
James P. Tobin retires from Neogen board effective May 31, 2025 after nine years of service.
-
Neogen hosts investor meeting on Petrifilm product line
Investor event held April 22, 2025, in Lansing, MI, focused on Petrifilm.
-
Neogen Q3 FY2025: revenue $221M, net loss $11M; updates guidance
Net loss of $11.0M ($0.05 diluted EPS); adjusted net income of $20.9M ($0.10 adjusted EPS).
-
Neogen CEO John Adent to step down; board forms search committee
John Adent will remain CEO/President until successor appointed; then serve as Special Advisor through Oct 31, 2025.
-
Neogen refinances $550M debt: new $450M term loan and $250M revolver at lower rate
Refinanced $550M of existing term loan and revolver due 2027; new $450M term loan and $250M revolver mature Apr 2030.
-
Neogen Q2 net loss $456.3M ($2.10/share) on goodwill impairment; adj EPS $0.11
Revenue $231.3M; net loss $456.3M ($2.10 diluted) primarily from non-cash goodwill impairment.
-
Neogen appoints David Naemura as COO alongside CFO; Doug Jones retiring Feb 28, 2025
David Naemura appointed COO effective Jan 1, 2025, retaining CFO role.
-
Neogen adds committee assignments for director Thierry Bernard
Amends prior 8-K to disclose committee roles for newly appointed director Thierry Bernard.
-
Neogen posts investor presentation for Piper Sandler Healthcare Conference
Neogen filed an 8-K on December 4, 2024, regarding its presentation at the 2024 Piper Sandler Healthcare Conference.
-
Neogen shareholders reject say-on-pay at 2024 annual meeting
Say-on-pay vote failed: 96,518,858 for vs. 101,431,438 against, 677,525 abstain.
-
Neogen Q1 net loss $12.6M; revenue down 5.3% YoY; guidance unchanged
Revenue $217.0M, down 5.3% YoY; core revenue declined 1.4%; currency headwind 3.9%.
-
Neogen COO Douglas E. Jones to retire early 2025; commercial role added
COO Douglas E. Jones plans retirement in early 2025; will facilitate transition of duties.
-
Neogen appoints QIAGEN CEO Thierry Bernard to board of directors
Thierry Bernard appointed to Neogen Board of Directors, effective November 1, 2024.
-
Neogen furnishes investor presentation for Wells Fargo Healthcare Conference
Presentation dated September 5, 2024, published for the 2024 Wells Fargo Healthcare Conference.
-
Neogen Q4 revenue $236.8M down 2.1% YoY; net loss $0.02 EPS; guides FY25 rev $925-955M
Revenue $236.8M, down 2.1% YoY; core revenue grew 2.0% as FX headwind of 4.2% offset.
-
Neogen furnishes investor presentation for William Blair Growth Stock Conference
Presentation materials published on June 4, 2024 for William Blair Growth Stock Conference.
-
Neogen reports Q3 revenue up 4.8% to $228.8M but net loss of $2.0M; cuts FY2024 outlook
Net loss of $2.0M ($0.01 diluted EPS) vs net income $8.2M ($0.04) a year ago.
-
Neogen appoints John Moylan as VP, Corporate Controller and CAO
John Moylan appointed VP, Corporate Controller, and Chief Accounting Officer effective April 15, 2024.
Executive changes
Departed
James P. Tobin
Director
NEOG ·
NEOGEN CORP
announces that James P. Tobin has chosen to retire from the Company’s Board of Directors, effective May 31, 2025.
Departed
John Adent
CEO and President
NEOG ·
NEOGEN CORP
On April 9, 2025 Neogen Corporation (the “Company”) announced that John Adent, the Company’s CEO and President, will be stepping down.
Departed
Doug Jones
Chief Operating Officer
NEOG ·
NEOGEN CORP
Doug Jones, who will be retiring as Chief Operating Officer effective February 28, 2025
Appointed
David Naemura
Chief Operating Officer
NEOG ·
NEOGEN CORP
David Naemura has been appointed Chief Operating Officer effective January 1, 2025, in addition to his role as Chief Financial Officer.
Departed
Douglas E. Jones
Chief Operating Officer
NEOG ·
NEOGEN CORP
Douglas E. Jones, Neogen’s Chief Operating Officer, has communicated his intent to retire in early 2025.
Appointed
Thierry Bernard
Director
NEOG ·
NEOGEN CORP
Neogen Corporation announced today that it has appointed Thierry Bernard to its Board of Directors.
Role change
David Naemura
Chief Financial Officer
NEOG ·
NEOGEN CORP
David Naemura will continue as the Company’s Chief Financial Officer and Mr. Moylan will serve as the Company’s Principle Accounting Officer, replacing Mr. Naemura in that role.
Appointed
John Moylan
Vice President, Corporate Controller, and Chief Accounting Officer
NEOG ·
NEOGEN CORP
John Moylan is appointed as Vice President, Corporate Controller, and Chief Accounting Officer of Neogen Corporation (the “Company”) effective April 15, 2024.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.80 · Median 0.53 · Most common event leadership